Journal profile · ONCOLOGY-RESPIRATORY SYSTEM
Thoracic Cancer
ISSN 1759-7706 · eISSN 1759-7714 · Blackwell Publishing Asia Pty Ltd · PEOPLES R CHINA · Founded 2010
Thoracic Cancer: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.55; fully open access; APC about USD 3,180; median 80 days to acceptance (90 articles, last 24 months); community-reported acceptance: about 75%; 279 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Thoracic Cancer is published by Blackwell Publishing Asia Pty Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations and Lung Cancer Research Studies, together about 45.1% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Thoracic Cancer is an international journal that aims to facilitate international collaboration and exchange of comprehensive and cutting-edge information on basic, translational, and applied clinical research in lung, esophageal, mediastinal, breast, and other thoracic malignancies. The editors encourage submissions relevant to thoracic surgery, medical oncology, therapeutic radiology, diagnostic imaging, pathology, and basic or translational research related to thoracic cancer. We also welcome submissions related to the prevention, epidemiology, and supportive/palliative care of thoracic cancer. Thoracic Cancer publishes a range of article types including: Original Article, Review, Mini Review, Editorial, Clinical Guideline, Technical Note, Meeting Report, Case Report, Letter to the Editor, Brief Report, Commentary, Study Protocols, Case Image and Insight.
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY-RESPIRATORY SYSTEM
Editor-in-chief Saba NoorPublisher website
Editorial board by country: 1 in mainland China (about 25%); most named Japan 2, Mainland China 1, India 1 (4 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Lung Cancer Diagnosis and TreatmentMedicine18.2%
- Lung Cancer Treatments and MutationsMedicine16.3%
- Lung Cancer Research StudiesMedicine10.5%
- Cancer Immunotherapy and BiomarkersMedicine8.4%
- Esophageal Cancer Research and TreatmentMedicine4.6%
- Pleural and Pulmonary DiseasesMedicine3.7%
- Tracheal and airway disordersMedicine3.3%
- Circular RNAs in diseasesBiochemistry, Genetics and Molecular Biology2.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 4 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPMCEmbaseCASCINAHLPublisher website
Other: EBSCO, ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.55LetPub ·
- Impact factor (publisher)
- 2.6Publisher website ·
- Impact factor (publisher) 2025
- 2.6Publisher website ·
- CiteScore 2026-06
- 5.2LetPub ·
- CiteScore (publisher)
- 5.2Publisher website ·
- CiteScore (publisher) 2025
- 5.2Publisher website ·
- SJR 2026-06
- 0.78LetPub ·
- SNIP 2026-06
- 0.83LetPub ·
- h-index
- 20LetPub ·
- h-index
- 70OpenAlex ·
- i10-index
- 1,566OpenAlex ·
- 2-year mean citedness
- 2.32OpenAlex ·
- Self-citation rate
- 3.8%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 215LetPub ·
- Articles per year (publisher)
- 2Publisher website ·
- Articles per year (publisher) 2025
- 219Publisher website ·
- Downloads per year (publisher) 2025
- 879,881Publisher website ·
Articles by year OpenAlex count · 4,183 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 189 | 189 | 20 |
| 2025 | 279 | 279 | 489 |
| 2024 | 349 | 349 | 1,384 |
| 2023 | 456 | 456 | 3,084 |
| 2022 | 496 | 496 | 4,979 |
| 2021 | 519 | 519 | 6,543 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
80 daysMedian, submission to acceptance · P25–P75 52 days – 122 days
- Acceptance to online
- median 15 days (91 articles)
- Submission to online
- median 101 days
- Sample
- 90 articles with submission and acceptance dates (503 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2 monthsLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
- Acceptance rate (publisher)
- 18%Publisher website ·
- Acceptance rate (publisher) 2025
- 18%Publisher website ·
- Submission to first decision
- 5 daysPublisher website ·
- Submission to first decision 2025
- 5 daysPublisher website ·
- Submission to acceptance 2025
- 80 daysPublisher website ·
- Acceptance to publication 2025
- 15 daysPublisher website ·
- Submission to publication (journal-reported)
- about 41 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,180 / GBP 2,040 / EUR 2,900 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 3,030 / EUR 2,760 / GBP 2,040 | — | — | |
| LetPub | USD 2,750 / GBP 1,850 / EUR 2,500 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare8 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 3–5
- Manuscript length
- ≤ 4,000 words
- Reference style
- Vancouver
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Required
- Graphical abstract
- Required
- Cover letter
- Required
Article types accepted14, with length limits
- brief reported in a way that proves its value. (12) Brief Reports Word limit: 1500 words including abstract but excluding references, tables and figmain text ≤ 1,500 words
- case reportsed paper for initial consideration (9) Case Reports Word limit: 1000 words maximum including abstract but excluding references, tablesmain text ≤ 1,000 words
- commentaryed paper for initial consideration. (8) Commentaries (or Insights) Word limit: 1500 words maximum excluding references. Abstract: not required. Refermain text ≤ 1,500 words
- editorialce or tone of a letter or response. (7) Editorials Word Limit: 1500 words maximum. Abstract: not required. References: 5 maximum. Desmain text ≤ 1,500 words
- editorials(7) Editorials Word Limit: 1500 words maximum. Abstract: not required. References: 5 maximum.Length not stated
- letters to the editor(6) Letters to the Editor Word limit: 500 words maximum. Abstract: not required. References: 4 maximum. Figures/tables: 1 maximum.Length not stated
- mini reviewgo peer review prior to acceptance. (3) Mini Reviews Word limit: 4000 words maximum including abstract but excluding references, tablesmain text ≤ 4,000 words
- mini reviews(3) Mini Reviews Word limit: 4000 words maximum including abstract but excluding references, tables and figures. Abstract: 250 words maximum, unstructured (no u…Length not stated
- original articleUSCRIPT CATEGORIES AND REQUIREMENTS (1) Original Articles Word limit: 4000 words maximum including abstract but excluding references, tablesmain text ≤ 4,000 words
- original articles(1) Original Articles Word limit: 4000 words maximum including abstract but excluding references, tables and figures. Abstract: 250 words maximum, with sub-head…Length not stated
- protocolll undergo full peer review. (13) Study Protocols Word limit: 5000 words maximum including abstract but excluding references, tablesmain text ≤ 5,000 words
- reviewn either basic or clinical science. (2) Reviews Word limit: 5000 words maximum including abstract but excluding references, tablesmain text ≤ 5,000 words
- reviews(2) Reviews Word limit: 5000 words maximum including abstract but excluding references, tables and figures. Abstract: 250 words maximum, unstructured (no use of…Length not stated
- technical noted paper for initial consideration. (11) Technical Notes Word limit: 1500 words including abstract but excluding references, tables and figmain text ≤ 1,500 words
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Publication ethics, License & copyright, Plagiarism, Trial registration / reporting guidelines
- Authorship Authorship and Acknowledgements
The journal adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). The ICMJE recommends that authorship be based on the following 4 criteria:i. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work;ii. Drafting the work or revising it critically for important…
Source ↗Publisher website ·- Conflicts of interest Disclosure
All articles are required to include a disclosure statement. The statement should disclose all potential conflicts of interest, including specific financial interests and relationships and affiliations (other than those affiliations listed in the title page of the manuscript) relevant to the subject of their manuscript. Authors without conflicts of interest should include a statement of no such in…
Source ↗Publisher website ·- Publication ethics Publication Ethics
Member of Committee on Publication Ethics (COPE) Model summary
This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley'sTop 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.
Source ↗Publisher website ·- License & copyright Reproduction of Copyright Material
If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is the author’s responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ at http://exchanges.wiley.com/authors/faqs---copyright-terms--conditions_301.html
Source ↗Publisher website ·- Plagiarism
Uses iThenticate CrossCheck for plagiarism detection Model summary
Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectivel…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Blackwell Publishing Asia Pty Ltd
- Country or region
- PEOPLES R CHINA
- Language
- English
- Founded
- 2010
- ISSN
- 1759-7706
- Electronic ISSN
- 1759-7714
- Latest issue on the website
- Volume 17, Issue 18 (September 2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Thoracic Cancer
What CAS zone is Thoracic Cancer in?
In the 2025 upgraded edition of the CAS Journal Ranking, Thoracic Cancer is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology / Respiratory System. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Thoracic Cancer?
The latest impact factor listed by LetPub is 2.55; CiteScore 5.2, h-index 70.
How long does peer review take at Thoracic Cancer?
Based on the dates recorded on 90 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 80 days (interquartile range 52–122 days); authors report an average review time of about 2 months; the community-reported acceptance is “about 75%”; the journal's website gives an acceptance rate of 18% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Thoracic Cancer?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 3–5; Manuscript length: ≤ 4,000 words; Reference style: Vancouver; First submission: Free format: the journal's layout is not required; Suggested reviewers: Required; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Thoracic Cancer based?
Of the 4 board members whose country the journal's board page names, 1 (about 25%) are in mainland China; the countries named most often are Japan (2), Mainland China (1) and India (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Thoracic Cancer?
According to LetPub and DOAJ records, Thoracic Cancer is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Web of Science, MEDLINE, PMC, Embase, CAS and CINAHL; that list has not been checked against each database.
Is Thoracic Cancer open access, and what is the APC?
Thoracic Cancer is a fully open-access journal. APC about USD 3,180.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .